| dc.contributor.author | Sah, R. | |
| dc.contributor.author | Abdelaal, A. | |
| dc.contributor.author | Asija, A. | |
| dc.contributor.author | Basnyat, S. | |
| dc.contributor.author | Sedhai, Y.R. | |
| dc.contributor.author | Ghimire, S. | |
| dc.contributor.author | Sah, S. | |
| dc.contributor.author | Katterine Bonilla-Aldana, D. | |
| dc.contributor.author | Rodriguez-Morales, A.J. | |
| dc.date.accessioned | 2025-10-31T18:32:43Z | |
| dc.date.available | 2025-10-31T18:32:43Z | |
| dc.date.issued | 2022 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12805/4750 | |
| dc.description.abstract | Monkeypox virus (MPXV), which resulted in sporadic outbreaks in the past, has recently re-emerged, reaching an alarming stage at a global level. Up to 5 July 2022, 6924 confirmed cases have been reported in 52 countries.1 Due to its pandemic potential, efforts should be directed towards its proper containment in a timely manner. Effective vaccination plays a critical role in this regard. Two FDA-licenced vaccines for smallpox have shown efficacy in providing cross-protection against MPXV... | en_US |
| dc.format | application/pdf | |
| dc.language.iso | eng | |
| dc.publisher | Oxford University Press | |
| dc.relation.ispartof | urn:issn:1195-1982 | |
| dc.rights | https://purl.org/coar/access_right/c_abf2 | |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/4.0/ | |
| dc.subject | Vaccination Strategies Against Emerging Viral Threats | en_US |
| dc.subject | Monkeypox Virus Dynamics and Public Health Response | en_US |
| dc.title | Monkeypox virus containment: the application of ring vaccination and possible challenges | en_US |
| dc.type | https://purl.org/coar/resource_type/c_545b | |
| dc.identifier.doi | https://doi.org/10.1093/jtm/taac085 | |
| dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.03.08 | |
| dc.type.other | Letter to the editor | |
| dc.identifier.journal | Journal of Travel Medicine | |
| dc.type.version | https://purl.org/coar/version/c_970fb48d4fbd8a85 | |